Moraxella catarrhalis

Background:

——————————————————————————
Gram-Negative Cocci & Coccobacilli   
——————————————————————————
>Aggregatibacter aphrophilus (formally known as Haemophilus aphrophilus)
>Bordetella pertussis (Causative agent of pertussis or whooping cough. )
>Brucella species:
     1] Brucella abortus
     2] Brucella canis
     3] Brucella melitensis
     4] Brucella suis
>Eikenella corrodens
>Haemophilus species:
     1] Haemophilus influenzae
     2] Haemophilus ducreyi
     3] Haemophilus avium
>Moraxella catarrhalis (formerly known as Branhamella catarrhalis) led
>Neisseria species:  (frequently colonize mucosal surfaces.)
     1] Neisseria gonorrhoeae
     2] Neisseria meningitidis
>Pasteurella multocida

Moraxella catarrhalis:  

  • fastidious, nonmotile, Gram-negative, aerobic, oxidase-positive diplococcus.
  • Can cause infections of the respiratory system (exacerbation of COPD, sinusitis, bronchitis, laryngitis, etc), middle ear (otitis media), eye, central nervous system, and joints of humans.

top of page

Therapy:

Important considerations:  The choice of an agent should be based on local antimicrobial sensitivities, site of infection, cost, and comorbid conditions.   Generally, the most common agents/regimens are listed first.   Listed dosages may need to be adjusted for renal dysfunction.  

  1. Augmentin 875/125 mg orally twice daily or  500/125mg three times daily or 1000mg XR (2 tabs=2000mg) q12h.
  2. Ceftin (cefuroxime oral) 500mg orally twice daily [2nd generation ceph]
  3. Cefprozil (Cefzil®) 500 mg po q12-24h. [2nd generation ceph]
  4. Cefpodoxime (Vantin ®) 200-400 mg orally twice daily   [3rd generation ceph]
  5. Azithromycin 500mg orally x 1 then 250mg  once daily for 4 days
  6. Clarithromycin 500mg po q12h  or Biaxin XL ®: 1000mg (500mg XL x 2) po qd
  7. Bactrim DS orally twice daily
  8. Levofloxacin 500mg – 750 mg IV/PO once daily

Disclaimer

The authors make no claims of the accuracy of the information contained herein; and these suggested doses are not a substitute for clinical judgment. Neither GlobalRPh Inc. nor any other party involved in the preparation of this program shall be liable for any special, consequential, or exemplary damages resulting in whole or part from any user’s use of or reliance upon this material.PLEASE READ THE DISCLAIMER CAREFULLY BEFORE ACCESSING OR USING THIS SITE. BY ACCESSING OR USING THIS SITE, YOU AGREE TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER. Read the disclaimer